Clinical trial
Safety and Efficacy of Platelet Lysate for Therapeutic Angiogenesis in Patients With Peripheral Arterial Disease
NCT02941419 is registered in ClinicalTrials.gov with University of Jordan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Platelet Lysate for Therapeutic Angiogenesis in Patients With Peripheral Arterial Disease
- Lead sponsor
- University of Jordan
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 5, 2013
- Completion date
- February 9, 2017
- Enrollment
- 10 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
critical limb ischemia